These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 20606628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent insights into C3 glomerulopathy.
    Barbour TD, Pickering MC, Cook HT.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1685-93. PubMed ID: 23479095
    [Abstract] [Full Text] [Related]

  • 4. C3 glomerulopathy - understanding a rare complement-driven renal disease.
    Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM.
    Nat Rev Nephrol; 2019 Mar; 15(3):129-143. PubMed ID: 30692664
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [Abstract] [Full Text] [Related]

  • 7. C3 glomerulopathy: what's in a name?
    D'Agati VD, Bomback AS.
    Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and treatment of C3 glomerulopathy in a center of expertise.
    Koopman JJE, Teng YKO, Boon CJF, van den Heuvel LP, Rabelink TJ, van Kooten C, de Vries APJ.
    Neth J Med; 2019 Jan; 77(1):10-18. PubMed ID: 30774098
    [Abstract] [Full Text] [Related]

  • 9. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases].
    He RJ, Xiao HJ, Wang SX, Guan N, Yao Y, Ding J.
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):939-43. PubMed ID: 23324154
    [Abstract] [Full Text] [Related]

  • 10. Update on C3 glomerulopathy.
    Barbour TD, Ruseva MM, Pickering MC.
    Nephrol Dial Transplant; 2016 May; 31(5):717-25. PubMed ID: 25326473
    [Abstract] [Full Text] [Related]

  • 11. C3 glomerulopathy and current dilemmas.
    Ito N, Ohashi R, Nagata M.
    Clin Exp Nephrol; 2017 Aug; 21(4):541-551. PubMed ID: 27878657
    [Abstract] [Full Text] [Related]

  • 12. C3 glomerulopathy: consensus report.
    Pickering MC, D'Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT.
    Kidney Int; 2013 Dec; 84(6):1079-89. PubMed ID: 24172683
    [Abstract] [Full Text] [Related]

  • 13. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH, Gitterman DP, Lavin DP, Lomax-Browne HJ, Hiemeyer EC, Moran LB, Boroviak K, Cook HT, Gilmore AC, Mandwie M, Ahmad A, Alexander IE, Logan GJ, Marchbank KJ, Bradley A, Pickering MC.
    Proc Natl Acad Sci U S A; 2021 Mar 30; 118(13):. PubMed ID: 33753502
    [Abstract] [Full Text] [Related]

  • 14. Update on C3 Glomerulopathy.
    Wooden B, Nester CM, Bomback AS.
    Adv Kidney Dis Health; 2024 May 30; 31(3):223-233. PubMed ID: 39004462
    [Abstract] [Full Text] [Related]

  • 15. Characterization of C3 in C3 glomerulopathy.
    Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJH.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):459-465. PubMed ID: 27507892
    [Abstract] [Full Text] [Related]

  • 16. The role of the alternative pathway of complement activation in glomerular diseases.
    Łukawska E, Polcyn-Adamczak M, Niemir ZI.
    Clin Exp Med; 2018 Aug 01; 18(3):297-318. PubMed ID: 29450785
    [Abstract] [Full Text] [Related]

  • 17. Complement and glomerular disease: new insights.
    Pickering M, Cook HT.
    Curr Opin Nephrol Hypertens; 2011 May 01; 20(3):271-7. PubMed ID: 21422921
    [Abstract] [Full Text] [Related]

  • 18. C3 Glomerulonephritis With Multiple Mutations in Complement Factor H.
    Dalili N, Behnam B, Vali F, Parvin M, Torbati P, Rasaii N, Samadian F, Ahmadpoor P.
    Iran J Kidney Dis; 2018 Nov 01; 12(6):376-381. PubMed ID: 30595568
    [Abstract] [Full Text] [Related]

  • 19. The role of complement in C3 glomerulopathy.
    Zipfel PF, Skerka C, Chen Q, Wiech T, Goodship T, Johnson S, Fremeaux-Bacchi V, Nester C, de Córdoba SR, Noris M, Pickering M, Smith R.
    Mol Immunol; 2015 Sep 01; 67(1):21-30. PubMed ID: 25929733
    [Abstract] [Full Text] [Related]

  • 20. C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum.
    Al-Ghaithi B, Chanchlani R, Riedl M, Thorner P, Licht C.
    Pediatr Nephrol; 2016 Nov 01; 31(11):2079-86. PubMed ID: 27008643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.